<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03675516</url>
  </required_header>
  <id_info>
    <org_study_id>P001</org_study_id>
    <nct_id>NCT03675516</nct_id>
  </id_info>
  <brief_title>Comorbidities and Outcomes in Early Rheumatoid Arthritis</brief_title>
  <official_title>The Epidemiology of Cardiovascular Disease, Haematological Abnormalities, and Other Comorbidities in Early Rheumatoid Arthritis in the United Kingdom and Their Associations With Important Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Momentum Data</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Momentum Data</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identify the burden of comorbidity at the time of diagnosis of rheumatoid arthritis. Identify
      the impact of comorbidity present at diagnosis on cardiovascular disease, death, rheumatoid
      arthritis disease progression and infections.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2018</start_date>
  <completion_date type="Actual">January 1, 2019</completion_date>
  <primary_completion_date type="Actual">January 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Time to a cardiovascular composite of incident myocardial infarction, stroke, or heart failure</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to all cause mortality</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to a composite of incident infections.</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
    <description>The composite will comprise incident upper respiratory tract infections, bronchitis, influenza-like illnesses, pneumonia, intestinal infectious diseases, herpes simplex, skin and soft tissue infections, urinary tract infections, and genital and perineal infections</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to incident myocardial infarction</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to incident stroke</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to incident heart failure</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to an extended cardiovascular composite comprised of incident myocardial infarction, stroke, heart failure, coronary artery disease, percutaneous coronary intervention, and angina</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to a joint operations composite comprised of incident joint operations on shoulder, elbow, wrist, hand, hip, knee, ankle and foot</measure>
    <time_frame>From diagnosis to loss to follow-up, or 1st January 2017</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">13182</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Rheumatoid arthritis cases</arm_group_label>
    <description>New onset cases of rheumatoid arthritis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Age, gender and primary care practice-matched controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No specific intervention</intervention_name>
    <description>Usual care</description>
    <arm_group_label>Controls</arm_group_label>
    <arm_group_label>Rheumatoid arthritis cases</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with newly diagnosed rheumatoid arthritis identified from their primary care
        records.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of rheumatoid arthritis prior to 1st January 2017

          -  Aged â‰¥18 years old

        Exclusion Criteria:

          -  Patients with another other rheumatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andy McGovern, BSc</last_name>
    <role>Study Director</role>
    <affiliation>Momentum Data</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Momentum Data Ltd</name>
      <address>
        <city>London</city>
        <zip>WC1X 8QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>September 14, 2018</study_first_submitted>
  <study_first_submitted_qc>September 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 18, 2018</study_first_posted>
  <last_update_submitted>March 12, 2019</last_update_submitted>
  <last_update_submitted_qc>March 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual patient data is confidential but can be made available in an anonymised form to bone fide researchers subject to the required data protection training and other requirements. All data will remain behind a firewall and will only be available for access through a secured computer network.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

